We aim to provide rare disease and neurological patients with therapies that significantly improve their condition and quality of life, allowing them to live the most fulfilling life and achieve their full potential.
Highlights
- Development specialist in rare diseases with high unmet need
- Proprietary drug delivery platforms, clinical & regulatory strategy, global B2B
- Commercial-stage portfolio complemented by 2 proprietary drug candidates